266 related articles for article (PubMed ID: 23921489)
1. Folate-targeted nanoparticles based on albumin and albumin/alginate mixtures as controlled release systems of tamoxifen: synthesis and in vitro characterization.
Martínez A; Olmo R; Iglesias I; Teijón JM; Blanco MD
Pharm Res; 2014 Jan; 31(1):182-93. PubMed ID: 23921489
[TBL] [Abstract][Full Text] [Related]
2. Targeting tamoxifen to breast cancer xenograft tumours: preclinical efficacy of folate-attached nanoparticles based on alginate-cysteine/disulphide-bond-reduced albumin.
Martínez A; Muñiz E; Teijón C; Iglesias I; Teijón JM; Blanco MD
Pharm Res; 2014 May; 31(5):1264-74. PubMed ID: 24218224
[TBL] [Abstract][Full Text] [Related]
3. Tamoxifen-loaded thiolated alginate-albumin nanoparticles as antitumoral drug delivery systems.
Martínez A; Benito-Miguel M; Iglesias I; Teijón JM; Blanco MD
J Biomed Mater Res A; 2012 Jun; 100(6):1467-76. PubMed ID: 22396108
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and characterisation of alginate/chitosan nanoparticles as tamoxifen controlled delivery systems.
Martínez A; Arana P; Fernández A; Olmo R; Teijón C; Blanco MD
J Microencapsul; 2013; 30(4):398-408. PubMed ID: 23489017
[TBL] [Abstract][Full Text] [Related]
5. Enhanced preclinical efficacy of tamoxifen developed as alginate-cysteine/disulfide bond reduced albumin nanoparticles.
Martínez A; Muñiz E; Iglesias I; Teijón JM; Blanco MD
Int J Pharm; 2012 Oct; 436(1-2):574-81. PubMed ID: 22850290
[TBL] [Abstract][Full Text] [Related]
6. Effective cellular internalization, cell cycle arrest and improved pharmacokinetics of Tamoxifen by cholesterol based lipopolymeric nanoparticles.
Mazumdar S; Italiya KS; Sharma S; Chitkara D; Mittal A
Int J Pharm; 2018 May; 543(1-2):96-106. PubMed ID: 29578081
[TBL] [Abstract][Full Text] [Related]
7. Characterization of novel composite alginate chitosan-carrageenan nanoparticles for encapsulation of BSA as a model drug delivery system.
Cheng L; Bulmer C; Margaritis A
Curr Drug Deliv; 2015; 12(3):351-7. PubMed ID: 26054536
[TBL] [Abstract][Full Text] [Related]
8. Design and characterization of calcium alginate microparticles coated with polycations as protein delivery system.
Zarate J; Virdis L; Orive G; Igartua M; Hernández RM; Pedraz JL
J Microencapsul; 2011; 28(7):614-20. PubMed ID: 21740107
[TBL] [Abstract][Full Text] [Related]
9. Folate mediated self-assembled phytosterol-alginate nanoparticles for targeted intracellular anticancer drug delivery.
Wang J; Wang M; Zheng M; Guo Q; Wang Y; Wang H; Xie X; Huang F; Gong R
Colloids Surf B Biointerfaces; 2015 May; 129():63-70. PubMed ID: 25829128
[TBL] [Abstract][Full Text] [Related]
10. Cholesterol-conjugated bovine serum albumin nanoparticles as a tamoxifen tumor-targeted delivery system.
Gharbavi M; Johari B; Eslami SS; Mousazadeh N; Sharafi A
Cell Biol Int; 2020 Dec; 44(12):2485-2498. PubMed ID: 32841441
[TBL] [Abstract][Full Text] [Related]
11. Gefitinib loaded folate decorated bovine serum albumin conjugated carboxymethyl-beta-cyclodextrin nanoparticles enhance drug delivery and attenuate autophagy in folate receptor-positive cancer cells.
Shi Y; Su C; Cui W; Li H; Liu L; Feng B; Liu M; Su R; Zhao L
J Nanobiotechnology; 2014 Oct; 12():43. PubMed ID: 25358257
[TBL] [Abstract][Full Text] [Related]
12. Paclitaxel-Loaded Folate-Targeted Albumin-Alginate Nanoparticles Crosslinked with Ethylenediamine. Synthesis and In Vitro Characterization.
Martínez-Relimpio AM; Benito M; Pérez-Izquierdo E; Teijón C; Olmo RM; Blanco MD
Polymers (Basel); 2021 Jun; 13(13):. PubMed ID: 34202848
[TBL] [Abstract][Full Text] [Related]
13. Folic acid conjugated bovine serum albumin: An efficient smart and tumor targeted biomacromolecule for inhibition folate receptor positive cancer cells.
Nosrati H; Abbasi R; Charmi J; Rakhshbahar A; Aliakbarzadeh F; Danafar H; Davaran S
Int J Biol Macromol; 2018 Oct; 117():1125-1132. PubMed ID: 29885392
[TBL] [Abstract][Full Text] [Related]
14. Preparation and characterization of folate conjugated N-trimethyl chitosan nanoparticles as protein carrier targeting folate receptor: in vitro studies.
Zheng Y; Cai Z; Song X; Chen Q; Bi Y; Li Y; Hou S
J Drug Target; 2009 May; 17(4):294-303. PubMed ID: 19255895
[TBL] [Abstract][Full Text] [Related]
15. Liver cancer cells: targeting and prolonged-release drug carriers consisting of mesoporous silica nanoparticles and alginate microspheres.
Liao YT; Liu CH; Yu J; Wu KC
Int J Nanomedicine; 2014; 9():2767-78. PubMed ID: 24940057
[TBL] [Abstract][Full Text] [Related]
16. Tamoxifen-loaded folate-conjugate poly[(p-nitrophenyl acrylate)-co-(N-isopropylacrylamide)] sub-microgel as antitumoral drug delivery system.
Blanco MD; Guerrero S; Benito M; Teijón C; Olmo R; Muñíz E; Katime I; Teijón JM
J Biomed Mater Res A; 2010 Dec; 95(4):1028-40. PubMed ID: 20872870
[TBL] [Abstract][Full Text] [Related]
17. Design, in silico modelling and functionality theory of folate-receptor-targeted myricetin-loaded bovine serum albumin nanoparticle formulation for cancer treatment.
Kunjiappan S; Govindaraj S; Parasuraman P; Sankaranarayanan M; Arunachalam S; Palanisamy P; Mohan UP; Babkiewicz E; Maszczyk P; Vellaisamy S; Panneerselvam T
Nanotechnology; 2020 Apr; 31(15):155102. PubMed ID: 31775133
[TBL] [Abstract][Full Text] [Related]
18. Folic acid-modified ginsenoside Rg5-loaded bovine serum albumin nanoparticles for targeted cancer therapy in vitro and in vivo.
Dong Y; Fu R; Yang J; Ma P; Liang L; Mi Y; Fan D
Int J Nanomedicine; 2019; 14():6971-6988. PubMed ID: 31507319
[TBL] [Abstract][Full Text] [Related]
19. Optimization of the preparation process of vinblastine sulfate (VBLS)-loaded folate-conjugated bovine serum albumin (BSA) nanoparticles for tumor-targeted drug delivery using response surface methodology (RSM).
Zu Y; Zhang Y; Zhao X; Zhang Q; Liu Y; Jiang R
Int J Nanomedicine; 2009; 4():321-33. PubMed ID: 20054435
[TBL] [Abstract][Full Text] [Related]
20. pH-sensitive Au-BSA-DOX-FA nanocomposites for combined CT imaging and targeted drug delivery.
Huang H; Yang DP; Liu M; Wang X; Zhang Z; Zhou G; Liu W; Cao Y; Zhang WJ; Wang X
Int J Nanomedicine; 2017; 12():2829-2843. PubMed ID: 28435261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
